Pharmaceutical Technology
DECEMBER 26, 2022
LegoChem Biosciences and Amgen have signed a multi-target research collaboration and license agreement to develop antibody-drug conjugates (ADC). Under the deal terms, Amgen was granted rights for the research, development, and commercialisation of ADCs that will be directed to treat up to five targets which are chosen by the company using the ConjuAll ADC technology of LegoChem.
NPR Health - Shots
DECEMBER 26, 2022
Call it "precision waking" — the alleged ability to decide when you want to wake up and then doing so, without an alarm. If you think you can do it, you're not alone, though how is still mysterious.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Medical Xpress
DECEMBER 26, 2022
Females, on average, are better than males at putting themselves in others' shoes and imagining what the other person is thinking or feeling, suggests a new study of over 300,000 people in 57 countries.
Drug Patent Watch
DECEMBER 26, 2022
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are seven…. The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Medical Xpress
DECEMBER 26, 2022
A cost-effectiveness analysis comparing direct oral anticoagulants (DOACs) to low-molecular-weight heparin (LMWH) found that DOACs are both more medically effective and cost-effective than LMWH when treating cancer-associated thrombosis (CAT). These findings may inform decisions on the clinical level as well as policy decisions. The analysis is published in Annals of Internal Medicine.
NPR Health - Shots
DECEMBER 26, 2022
The scrapping of the quarantine requirement starting Jan. 8 is a major step toward reopening travel with the rest of the world, which the government severely curtailed in a bid to keep the virus out.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
JAMA Internal Medicine
DECEMBER 26, 2022
This cluster randomized clinical trial aims to determine whether provision of COVID-19 vaccine messaging platforms in emergency departments increases COVID-19 vaccine acceptance and uptake in unvaccinated patients.
Medical Xpress
DECEMBER 26, 2022
Chinese authorities are going door to door and paying people older than 60 to get vaccinated against COVID-19. But even as cases surge, 64-year-old Li Liansheng said his friends are alarmed by stories of fevers, blood clots and other side effects.
Drug Patent Watch
DECEMBER 26, 2022
[
Medical Xpress
DECEMBER 26, 2022
Chinese President Xi Jinping urged officials on Monday to take steps to protect lives in his first public remarks on COVID-19 since Beijing dramatically loosened hardline containment measures this month.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Drug Patent Watch
DECEMBER 26, 2022
[
Medical Xpress
DECEMBER 26, 2022
A British historian, an Italian archaeologist and an American preschool teacher have never met in person, but they share a prominent pandemic bond.
Drug Patent Watch
DECEMBER 26, 2022
VICTOZA (liraglutide recombinant) Novo nordisk inc Patent: 8,846,618 Expiration: Dec 27, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…. The post Drug Patent Expirations for the Week of December 25, 2022 appeared first on DrugPatentWatch - Make Better Decisions.
Medical Xpress
DECEMBER 26, 2022
Spontaneous, random baby movements aid development of their sensorimotor system, according to new research led by the University of Tokyo. Detailed motion capture of newborns and infants was combined with a musculoskeletal computer model to enable researchers to analyze communication among muscles and sensation across the whole body.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Drug Patent Watch
DECEMBER 26, 2022
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are twenty-five patents protecting…. The post New patent expiration for NOVO drug SAXENDA appeared first on DrugPatentWatch - Make Better Decisions.
Medical Xpress
DECEMBER 26, 2022
The key to keeping skin soft in winter: Moisturize.
BioSpace
DECEMBER 26, 2022
Mergers and acquisitions are expected to be a key theme in the pharmaceutical industry in 2023.
Drug Patent Watch
DECEMBER 26, 2022
This chart shows the pharmaceutical companies with the most emulsion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most emulsion dosed drugs…. The post Which pharmaceutical companies have the most emulsion dosed drugs? appeared first on DrugPatentWatch - Make Better Decisions.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
XTalks
DECEMBER 26, 2022
On Target Laboratories, Inc. has obtained US Food and Drug Administration (FDA) approval of an expanded indication for the use of Cytalux (pafolacianine) for the detection of lung cancer during surgery. This biotech company discovers and develops targeted intraoperative molecular imaging agents to illuminate cancer during surgery. In November 2021, Cytalux received FDA approval to assists surgeons in visually identifying additional malignant tissue in ovarian cancer to be removed during the oper
Pharmaceutical Technology
DECEMBER 26, 2022
The once cut-throat business landscape is evolving, and business ecosystems are on the rise. Open APIs are facilitating unprecedented collaboration, enabling businesses to pool their resources and expertise to develop better solutions for end users. The opportunities for new innovations and functionalities are enormous. “Companies have long looked at collaboration to increase value, but the idea of expanding such partnerships on a technical basis was enabled by the rise of the internet and linke
Expert insights. Personalized for you.
130 
Let's personalize your content